Building Patient Trust: Empowering Patients to Participate in Clinical Studies

Reading Time: 4 minutes This blog was authored by Paul Chang, SVP, Design and… Read More

Quick Take: Medidata & Harvard Business Review Talk Decentralized Clinical Trials

Reading Time: 2 minutesDecentralized clinical trials (DCTs) have revolutionized clinical research. As trials become… Read More

Is Clinical Trial Diversity the New Patient Centricity?

Reading Time: 2 minutesThis blog was authored by Alicia Staley. Alicia is the VP… Read More

Managing Clinical Trial Data in a Fast-paced, Complex Environment

Reading Time: 4 minutesThe world of clinical data management is rapidly changing, and so… Read More

Medidata AI: New Research on Concurrence of CRS and ICANS in CAR T-cell Treatments

Reading Time: < 1 minutesChimeric antigen receptor (CAR) T-cell treatment is a promising immunotherapy… Read More

4 Ways Linking CAR-T Therapy Patients to Real-world Data Is Future-proofing Clinical Development

Reading Time: 4 minutesChimeric antigen receptor T-cell (CAR-T) therapies have demonstrated significant… Read More

Risk-based Quality Management Growing Rapidly in Clinical Trials: ACRO RBQM Working Group

Reading Time: 2 minutesClinical trials are constantly evolving in response to technological advances, new… Read More

Accelerating Generalizability of Cancer Clinical Trial Results

Reading Time: 4 minutesSubstantial research suggests that patients participating in cancer clinical trials of new therapies… Read More

2022: A Remarkable Year for External Control Arms in Clinical Trials

Reading Time: 5 minutes2022 was a remarkable year for external control arms (ECAs) in… Read More

Introducing the Medidata Knowledge Hub

Reading Time: 2 minutesThe Medidata Knowledge Hub is a new, state-of-the-art… Read More